A Chinese patient with peritoneal dialysis-related peritonitis caused by Gordonia terrae: a case report by Chenrui Hou et al.
CASE REPORT Open Access
A Chinese patient with peritoneal dialysis-
related peritonitis caused by Gordonia
terrae: a case report
Chenrui Hou*, Yun Yang and Ziyang Li
Abstract
Background: Gordonia terrae is a rare cause of clinical infections, with only 23 reported cases. We report the first
case of peritoneal dialysis-related peritonitis caused by Gordonia terrae in mainland China.
Case presentation: A 52-year-old man developed peritoneal dialysis-related peritonitis and received preliminary
antibiotic treatment. After claiming that his symptoms had been resolved, the patient insisted on being discharged
(despite our recommendations) and did not receive continued treatment after leaving the hospital. A telephone
follow-up with the patient’s relatives revealed that the patient died 3 months later. Routine testing did not identify
the bacterial strain responsible for the infection, although matrix-assisted laser desorption/ionization time-of-flight
mass spectrometry identified the strain as Gordonia rubropertincta. However, a 16S rRNA sequence analysis using an
isolate from the peritoneal fluid culture revealed that the responsible strain was actually Gordonia terrae. Similar to
this case, all previously reported cases have involved a delayed diagnosis and initial treatment failure, and the definitive
diagnosis required a 16S rRNA sequence analysis. Changes from an inappropriate antibiotic therapy to an appropriate
one have relied on microbiological testing and were performed 7–32 days after the initial treatment.
Conclusions: The findings from our case and the previously reported cases indicate that peritoneal dialysis-related
peritonitis caused by Gordonia terrae can be difficult to identify and treat. It may be especially challenging to diagnose
these cases in countries with limited diagnostic resources.
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Background
Gordonia terrae is a gram-positive, coccoid to bacillary,
weakly acid-fast bacterium that was initially isolated
from soil and is a rare cause of clinical infection. Unfor-
tunately, the Gordonia spp. are not identifiable using
Gram staining of clinical specimens, and definitive iden-
tification may require the use of a 16S rRNA sequence
analysis. We report the first case of peritoneal dialysis-
related peritonitis caused by Gordonia terrae in main-
land China. Matrix-assisted laser desorption/ionization
time-of-flight mass spectrometry initially identified the
responsible strain as Gordonia rubropertincta, although
definitive identification was achieved using a 16S rRNA
sequence analysis. To the best of our knowledge, only 23
similar cases have been reported in the English literature
(Table 1).
Case presentation
Medical history of the patient
A 52-year-old man was diagnosed with uraemia at a
local hospital in February 2013. He was treated using
haemodialysis while in the hospital and with peritoneal
dialysis after discharge. His serum creatinine concentra-
tion was 1000 μmol/L, showing two reduced renal volume.
The patient was also diagnosed with chronic obstructive
pulmonary disease, grade 3 hypertension (high-risk), and
cardiac insufficiency. Starting in June 2015, the patient
reported experiencing epigastric pain during the peritoneal
dialysis, which was exacerbated during inspiration, relieved
during dialysis fluid removal, and absent during non-
dialysis periods. The dialysis fluids were smooth and
accompanied by floccule.
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On November 17, 2015, the patient experienced
bloody ascites, swelling of both lower limbs, and asthma
after playing sports and was admitted to our hospital. A
physical examination revealed a body temperature of
38.0 °C, a respiratory rate of 22 breaths/min, a pulse of
110 beats/min, and blood pressure of 130/63 mmHg.
The patient showed clear consciousness, but he exhibited
facial signs of chronic anaemia, distension of the jugular
vein, barrel chest, mild swelling of both lower limbs,
wheezing in both lungs, an expanded heart boundary on
two sides, abdominal wall tension, positive pressure at the
navel, and no rebound tenderness. Laboratory testing
revealed a white blood cell count of 3.4 × 109/L, a procal-
citonin level of 2.69 ng/mL, a B-type natriuretic peptide
level of 460 pg/mL, a prothrombin time of 14.5 s, and a
D-dimer level of 2,127 ng/mL. Routine testing of the peri-
toneal fluid revealed a slightly muddy appearance with a
specific gravity of 1.018, weak positive results in the
Rivalta test, a white blood cell count of 510 × 106/L
(mononuclear cells: 40%, multinuclear cells: 60%), a red
blood cell count of 2,980 × 106/L, and positive results for
coagulability.
The patient’s peritoneal fluid was submitted for culturing,
and the patient received initial treatment using intravenous
cefazolin, which was changed to intraperitoneal ceftazidime
and vancomycin on November 19. On November 23, the
patient’s body temperature was 36.5 °C. He reported that
his chest congestion and stomach ache were relieved, and
the dialysis fluid appeared smooth and clear. The patient
and his relatives insisted that he be discharged, despite our
informing them that the culture results were incomplete,
the infection might not be controlled, and the patient
might experience recurrence of the peritonitis and sep-
ticopyaemia. Unfortunately, a telephone follow-up with
Table 1 Literature reports of infections caused by Gordonia terrae (1992–2016)
No. Author Pt age
(years)
Pt sex Pt Country Clinical manifestation Days to
Dx after Ad





1 Drancourt et al. 3 M USA fever, headache 24 C + SH + HPLC Ct + M V + To [3]
2 Pham et al. 28 M USA fever, chills, headache 7–9 C + 16S Cz V [4]
3 Pham et al. 44 F USA fever, 7–9 C + 16S Cz V [4]
4 Pham et al. 54 F USA fever, 7–9 C + 16S L+ Imp V [4]
5 Pham et al. 46 F USA fever, chills 7–9 C + 16S E V+ Imp [4]
6 Pham et al. 60 M USA fever, chills, orthostatic
hypotension
7–9 C + 16S At Cd + Az [4]
7 Drancourt et al. 40 F France fever, hemiparesis 7 C + 16S SMZ + OF V [12]
8 Bakker et al. 15 M Netherlands fever, thumb pain 14 C + 16S D NA [13]
9 Gil-Sande et al. 61 M Spain fever, urine retention,
altered mental status
20 C + 16S PT + G NA [5]
10 Nicodemo et al. 55 F Brazil fever, nausea 15 C + 16S PT + V Imp + Ci [6]
11 Lai et al. 58 F Taiwan fever NA C + 16S Imp + Ci V [7]
12 Lai et al. 23 M Taiwan fever, bone pain NA C + 16S Imp V [7]
13 Lai et al. 75 M Taiwan fever NA C + 16S Ci V [7]
14 Lai et al. 30 M Taiwan fever NA C + 16S AC NA [7]
15 Lai et al. 48 M Taiwan fever, cough NA C + 16S AC NA [7]
16 Ma et al. 45 M Hong Kong abdominal pain 21 C + 16S Ca + Cz V [10]
17 Ma et al. 61 M Hong Kong NA 13 C + 16S Ci + Ca + Cz V [10]
18 Ma et al. 60 M Hong Kong NA 12 C + 16S Ca + Cz Mem [10]
19 Blanc et al. 41 F France eye smarting >3 C + 16S NA NA [2]
20 Grisold et al. 24 M Austria fever, dyspnoea,
nausea, and vomiting
NA C + 16S L + PT NA [14]
21 Zardawi et al. 29 F Australia mass in breast >7 C + 16S NA Te [15]
22 Zampella et al. 56 F USA mass on foot NA C + 16S SMZ AC [16]
23 Aoyama et al. NA NA Japan pulmonary infections NA C + 16S NA NA [17]
Ad admitted, C culture, Dx diagnosis, NA data not available, SH southern hybridization, HPLC high performance liquid chromatography, Pt patient, Ref reference,
AC amoxicillin-clavulanate, Az azithromycin, At atreonam, Cd clindamycin, Ct ceftriaxone, Ca cefazolin, Cz ceftazidime, Ci ciprofloxacin, D doxycycline, E
erythromycin, G gentamicin, Mem meropenem, Imp imipenem, L levofloxacin, M metronidazole, OF ofloxacin, PT piperacillin/tazobactam, SMZ sulfamethoxazole, To
tobramycin, Te tetracycline, V vancomycin
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the patient’s relatives revealed that he had not received
continued treatment after his discharge and had died in
February 2016. The cause of death was multiorgan failure.
Bacteria culture and identification
On November 19, 2015, the patient’s peritoneal fluid
was aseptically collected into aerobic blood culture bottles
(BD, USA) and sent to a clinical laboratory, where it was
cultured using the BactecTM 9120 blood culture system
(BD, USA). After culturing for 51.76 h, a positive result
was observed, and the culture fluid was directly smeared
to identify gram-positive bacilli. The fluid was also trans-
ferred to blood agar (Zhengzhou Autobio) and chocolate
agar plates (Tianjin Jinzhang), which were incubated at
35 °C with 5% CO2. There were no visible colonies after
24 h of culturing, although both plates exhibited small
light-brown colonies after 48 h of culturing. The colonies
were positive in the catalase test. After 72 h on the choc-
olate agar plate and 6 days on the blood agar plate, the
colonies were dry, cracked, elevated, and light brown in
colour (Figs. 1 and 2). Figures 3 and 4 show that the
colonies were confirmed to be gram-positive bacilli
with positive, weak acid-fast staining. Additional testing
using the MicrolexLT/SH mass spectrometer (Bruker)
identified the strain as G. rubropertincta with a score of
1.702. However, a 16S rRNA sequence analysis was also
performed at the Shanghai Sangon Company, using the fol-
lowing primers: 27 F (5′-GAGTTTGATCCTGGCTCAG-
3′) and 1492R (5′-AAGGAGGTGATCCAGCCGCA-3′)
[1]. After Blast alignment, we observed that the bacteria
were 99% similar to the sequence of G. terrae EY-T12
(GenBank: KR476419.1). The phylogenetic tree of the
20160601 isolate is shown in Fig. 5.
Antimicrobial susceptibility test
An antimicrobial susceptibility testing was performed
using the E-test (Zhengzhou Autobio), in which in the
McFarland and M-H plates (Tianjin Jinzhang) are
adjusted to 0.5 and incubated at 35 °C with 5% CO2
for 48 h. The results from the patient described in this
report and from those in previous studies are summa-
rized in Table 2. The strains in the previous studies
were also tested using the E-test after 48 h of incuba-
tion. The isolate from the present report was resistant
to ceftazidime and susceptible to penicillin, ampicillin,
amikacin, erythromycin, ceftriaxone, imipenem, gentamicin,
and vancomycin.
Fig. 1 The colonies on a chocolate agar plate after 72 h of incubation
Fig. 2 The colonies on a blood agar plate after 6 days of incubation
Fig. 3 Gram staining (magnification: 1,000×)
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Discussion
The Gordonia genus includes 29 species, including G.
bronchialis, G. aichiensis, G. rubropertincta, G. sputi, and
G. terrae, which are associated with human disease [2]. G.
terrae is an aerobic bacillus that grows slowly (a culture
time of >48 h is needed) and is most frequently identified
in the environment. However, G. terrae also infects
patients with reduced immune status and causes brain
abscesses, duct-associated blood infections, and chole-
cystitis and nephrapostasis after transplantation [3–6].
Lai et al. retrospectively identified 7 G. terrae strains
from among 15 Gordonia strains from 9 cases of infection
at a Taiwanese university hospital (1997–2008), and all
infected patients had a reduced immune status [7].
Unfortunately, Gordonia, Rhodococcus, Nocardia, and
Mycobacterium are all actinomycetes and can easily be
misidentified during smear microscopic analysis and
biochemical testing. In addition, G. terrae can metabolize
rhamnose and produce acid, but cannot metabolize raffi-
nose, which may increase the likelihood of confusing it with
Rhodococcus. Nocardia can generate aerial hyphae on blood
agar plates and provide positive results during lysozyme
resistance testing, while Mycobacterium might also be
confused with G. terrae based on its production of mycolic
acid during high-performance liquid chromatography [8].
Therefore, the definitive identification of these bacteria
should be performed using 16S rRNA sequence analysis.
Peritoneal dialysis is the main therapy for patients with
end-stage renal failure, although patients with a reduced
immune status may easily experience peritonitis. A 15-
year retrospective analysis of infectious peritonitis asso-
ciated with peritoneal dialysis in China revealed that the
identification rate of gram-positive bacilli increased from
0% during 1990–2000 to 5.6% during 2001–2005 [9]. In
addition, four cases of peritoneal dialysis-related periton-
itis involved bacilli found to be gram-positive on the
third day of culturing, with 3 cases that involved G. terrae.
However, identification of G. terrae took 7–32 days, and
the antibiotics were subsequently changed from cefazolin
to vancomycin [10]. In the present case, the patient’s peri-
toneal fluid was confirmed as being gram-positive after
51.76 h of culturing, although 15 days were required to
complete the definitive identification of the bacteria,
which prevented us from adjusting the patient’s antibiotic
treatment because he had been discharged before we ob-
tained the definitive identification. The mass spectrometry
results correctly identified the isolate as Gordonia,
although it incorrectly identified the species. Thus,
although mass spectrometry is convenient and rapid, it
may not be able to accurately identify rare bacterial
strains. After we confirmed the isolate’s identity using
16S rRNA sequencing, we contacted the mass spec-
trometry engineer and reconstructed spectrograms for
the species.
Interestingly, we have not found any evidence regarding
the appropriate antibiotic therapy for Gordonia. Johnson
et al. reported that G. terrae is sensitive to most antibiotics
(including β-lactams, glycopeptides, and carbapenems),
although the treatment course is too long for patients
with peritonitis [11]. For example, the previous reports
regarding G. terrae indicated that at least 3 weeks of
Fig. 4 Weak acid fast staining (magnification: 1,000×)
Fig. 5 Phylogenetic tree of the isolate
Hou et al. BMC Infectious Diseases  (2017) 17:179 Page 4 of 5
vancomycin therapy were needed to prevent secondary
infections. Therefore, clinicians should carefully consider
the development of secondary peritonitis in patients with
peritoneal dialysis caused by G. terrae. In addition, efforts
should be made to rapidly and definitively identify the
responsible strain in order to facilitate effective therapy.
Conclusions
The present case is the first report of an peritoneal
dialysis-related peritonitis caused by Gordonia terrae in
mainland China. The findings from our case and the
previously reported cases indicate that peritoneal dialysis-
related peritonitis caused by Gordonia terrae can be diffi-
cult to identify and treat. It may be especially challenging
to diagnose these cases in countries with limited diagnostic
resources. In addition, resistance to the antimicrobial
agents were observed in isolates from the present patient
as well as previous reports.
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Ceftriaxone 0.75 0.19 to >512
Ceftazidime >256 2.0 to >256
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